About | Free Trial

Last Update

2016-04-22T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Brigham Hyde?

Dr. Brigham Hyde

Vice President, Data Science

Decision Resources Group

Direct Phone: (781) ***-****       

Email: b***@***.com

Decision Resources Group

8 New England Executive Park

Burlington, Massachusetts 01803

United States

Company Description

Decision Resources Group Consulting strives to enhance the topline growth of our customers. Our solutions are based on comprehensive product, pipeline, competitor and global marketplace analyses for our clients in the healthcare space. Our efforts are sup ... more

Find other employees at this company (714)

Background Information

Employment History

Adjunct Professor of Pharmacology and Experimental Therapeutics
Tufts University

Equity Research Analyst In Medical Technology and Life Science Tools
Cowen Group, Inc.

Affiliations

Founder
Relay Technology Management Inc

Member of the Research Team
Healthcare Equity

Education

B.S.
Chemistry
Northeastern University

Ph.D.

Ph.D.
Clinical Pharmacology
Tufts University School of Medicine

Web References (66 Total References)


Brigham ...

www.mitcio.com, $reference.date [cached]

Brigham Hyde

Chief Data Officer
Decision Resources
...
Brigham Hyde, Ph.D., is the Chief Data Officer and SVP of Analytics at Decision Resources Group where he leads client direct data analytics for Life Sciences. Brigham Joined DRG as part of the acquisition of Relay Technology Management in January 2014. As CEO and co-founder of Relay Technology Management he developed proprietary analytics software and data aggregation tools. Dr. Hyde has over 10 years life science experience and prior to founding Relay Technology Management was an equity research analyst in Medical Technology and Life Science Tools at Cowen & Co. in Boston. Dr. Hyde brings knowledge both of basic science research and drug development operations. He has conducted research in mitochondrial pharmacology and biology in the context of anemia, myelodysplastic syndromes, and type II diabetes. Dr.Hyde received his Ph.D. in Clinical Pharmacology from the Tufts University School of Medicine, where he is currently an adjunct professor of Pharmacology and experimental therapeutics.


"Our next-generation analytics services ...

medpanel.com, $reference.date [cached]

"Our next-generation analytics services are even more powerful when combined with MedPanel's expertise in primary research and skill in teasing out powerful market-driven insights," says Brigham Hyde, Managing Director of Relay Technology Management.


Relay Selects TIBCO Spotfire for Real-Time BI and Data Visualization | TIBCO

www.cn.tibco.com, $reference.date [cached]

"Life Sciences companies including Pfizer, Cubist Pharmaceuticals, and Stromedix (recently acquired by BiogenIdec) are using dashboards powered by Spotfire in BD Live! to answer questions such as 'Who are the best gram negative anti-bacterial researchers?', 'What's the historical licensing trend for a given drug and what does it mean for how I should be structuring current deals?'," said Brigham Hyde, Ph.D., Relay TM's co-founder and managing director. "With one click, users can drill into a visual presentation of the results to explore data sets in really intuitive ways and leading to more insight and better decisions."

Combining Best-in-Class Visualization-Based Data Discovery and Unified Information Access
"Spotfire, combined with Attivio's Active Intelligence Engine (AIE), enables us to deliver greater insight across a broader range of data for our customers - the ability to free text search through document sets directly, which allows users to create custom cuts of data visualizations," noted Hyde. "Being able to deliver a streamlined approach without having to build an intermediate infrastructure is critical to our go-to-market strategy."
The Relay Innovation Engine, which BD Live! is built on, utilizes proprietary ontologies and data architecture that leverage TIBCO Spotfire® visualization-based data discovery as the front-end, and Attivio's unified information access technology in the back-end.
"The ability to visualize the data in a meaningful way was essential to communicate the meaning of the back-end to users," noted Hyde.


Relay Selects TIBCO Spotfire for Real-Time BI and Data Visualization | TIBCO

www.kr.tibco.com, $reference.date [cached]

"Life Sciences companies including Pfizer, Cubist Pharmaceuticals, and Stromedix (recently acquired by BiogenIdec) are using dashboards powered by Spotfire in BD Live! to answer questions such as 'Who are the best gram negative anti-bacterial researchers?', 'What's the historical licensing trend for a given drug and what does it mean for how I should be structuring current deals?'," said Brigham Hyde, Ph.D., Relay TM's co-founder and managing director. "With one click, users can drill into a visual presentation of the results to explore data sets in really intuitive ways and leading to more insight and better decisions."

Combining Best-in-Class Visualization-Based Data Discovery and Unified Information Access
"Spotfire, combined with Attivio's Active Intelligence Engine (AIE), enables us to deliver greater insight across a broader range of data for our customers - the ability to free text search through document sets directly, which allows users to create custom cuts of data visualizations," noted Hyde. "Being able to deliver a streamlined approach without having to build an intermediate infrastructure is critical to our go-to-market strategy."
The Relay Innovation Engine, which BD Live! is built on, utilizes proprietary ontologies and data architecture that leverage TIBCO Spotfire® visualization-based data discovery as the front-end, and Attivio's unified information access technology in the back-end.
"The ability to visualize the data in a meaningful way was essential to communicate the meaning of the back-end to users," noted Hyde.


Board of Directors | Relay Technology Management

relaytm.com, $reference.date [cached]

Brigham Hyde, Ph.D., Co-founder & Managing Director

Dr. Hyde is a cofounder of Relay Technology Management, Inc. and currently serves as Managing Director. Dr. Hyde was most recently an equity research analyst at Cowen and Company, as a member of the Healthcare Equity Research team with a focus on life science tools, genetic technologies, diagnostics, and the broader Medtech industry. Dr. Hyde is an Adjunct Professor and Lecturer at Tufts University Sackler School of Biomedical Science in the Department of Pharamcology. He has experience in pre-clinical drug development from CRO Wolfe Laboratories Inc. and has conducted research and published several articles in pharmacology and mitochondrial biology in the context of anemia, myelodysplastic syndromes, and type II diabetes. Dr. Hyde received his B.S. in Chemistry and a minor in Business Management from Northeastern University and a Ph.D.in Pharmacology and Experimental Therapeutics from Tufts University Sackler School of Biomedical Science. Dr. Hyde also publishes his perspectives on the emerging field of personalized medicine and genetic technology on his personal blog www.basepairstobedside. com.

Similar Profiles

Other People with this Name (15,985)

Other people with the name Hyde

Chris Hyde
Mitigram

Kimberly Hyde
American Samoa Bar Association

Florence Hyde
Brentwood School

Tristram Hyde

Alex Hyde
Mortgage Bureau

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory